Presence of CLA-1 and HDL binding sites on syncytiotrophoblast brush border and basal plasma membranes of human placenta

被引:26
作者
Lafond, J
Charest, MC
Alain, JF
Brissette, L
Masse, A
Robidoux, J
Simoneau, L
机构
[1] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada
[2] Univ Montreal, Fac Med, Dept Obstet Gynecol, Montreal, PQ H3C 3J7, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
D O I
10.1053/plac.1999.0412
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
It is now known that rapid placental and fetal development is associated with elevated levels of circulating high density lipoprotein (HDL) in pregnant women. The main structure implicated in the maternal-fetal exchange is the syncptiotrophoblast, composed of a brush border membrane (BBM), facing the mother, and a basal plasma membrane (BPM), facing the fetus. In order to understand the mechanisms controlling the placental and fetal supplies of cholesterol, we purified both BBM and BPM and verified the presence of HDL binding sites in these membranes. Binding studies using I-125-HDL3 show a single affinity binding site on BPM which has a dissociation constant (K-d) Of 3.45 +/- 0.43 mu g protein/ml and a maximal binding capacity (B-max) of 5.46 +/- 1.69 mu g protein/mg membrane proteins. In BBM, we observed two affinity binding sites, one with K-d of 0.62 +/- 0.83 mu g protein/ml and another one with a K-d of 6.57 +/- 0.87 mu g protein/ml. Their B-max values were 0.54 +/- 0.11 and 2.34 +/- 0.39 mu g of HDL3/mg membrane proteins, respectively. CLA-1, a putative HDL-receptor of 85 kDa, was detected on both BPM and BBM, together with two apo A-l binding sites of 110 and 96 kDa on BPM and BBM, respectively. These results provide further evidence that human placenta possesses specific sites for HDL binding, underlining the important role of maternal HDL in the transfer of cholesterol from the maternal circulation to the placenta and the fetus. (C) 1999 Harcourt Publishers Ltd.
引用
收藏
页码:583 / 590
页数:8
相关论文
共 52 条
[1]   Identification of scavenger receptor SR-BI as a high density lipoprotein receptor [J].
Acton, S ;
Rigotti, A ;
Landschulz, KT ;
Xu, SZ ;
Hobbs, HH ;
Krieger, M .
SCIENCE, 1996, 271 (5248) :518-520
[2]   HIGH-DENSITY-LIPOPROTEIN INTERACTION WITH HUMAN PLACENTA - BIOCHEMICAL AND ULTRASTRUCTURAL CHARACTERIZATION OF BINDING TO MICROVILLOUS RECEPTOR AND LACK OF INTERNALIZATION [J].
ALSAT, E ;
MALASSINE, A .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1991, 77 (1-3) :97-108
[3]   LOW-DENSITY LIPOPROTEIN BINDING-SITES IN THE MICROVILLOUS MEMBRANES OF HUMAN-PLACENTA AT DIFFERENT STAGES OF GESTATION [J].
ALSAT, E ;
BOUALI, Y ;
GOLDSTEIN, S ;
MALASSINE, A ;
BERTHELIER, M ;
MONDON, F ;
CEDARD, L .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1984, 38 (2-3) :197-203
[4]   CHARACTERIZATION OF SPECIFIC LOW-DENSITY LIPOPROTEIN BINDING-SITES IN HUMAN TERM PLACENTAL MICROVILLOUS MEMBRANES [J].
ALSAT, E ;
BOUALI, Y ;
GOLDSTEIN, S ;
MALASSINE, A ;
LAUDAT, MH ;
CEDARD, L .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1982, 28 (03) :439-453
[5]   SPECIFIC BINDING OF FREE APOLIPOPROTEIN-A-I TO A HIGH-AFFINITY BINDING-SITE ON HEPG2 CELLS - CHARACTERIZATION OF 2 HIGH-DENSITY-LIPOPROTEIN SITES [J].
BARBARAS, R ;
COLLET, X ;
CHAP, H ;
PERRET, B .
BIOCHEMISTRY, 1994, 33 (08) :2335-2340
[6]   METABOLISM OF MODIFIED LDL BY CULTURED HUMAN PLACENTAL CELLS [J].
BONET, B ;
CHAIT, A ;
GOWN, AM ;
KNOPP, RH .
ATHEROSCLEROSIS, 1995, 112 (02) :125-136
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]  
BRISSETTE L, 1986, J BIOL CHEM, V261, P6847
[9]  
CALVO D, 1993, J BIOL CHEM, V268, P18929
[10]   CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins [J].
Calvo, D ;
GomezCoronado, D ;
Lasuncion, MA ;
Vega, MA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2341-2349